Yahoo
NYSE USD

Koninklijke Philips N.V. (PHG)

26.92 -0.20 (-0.74%)
At close: October 30 at 4:00:02 PM EDT
26.92 0.00 (0.00%)
After hours: October 30 at 4:01:06 PM EDT
Trade PHG on Coinbase
PHG Q3 2026 earnings call
November 3, 2026 at 4 AM EST
Chart Range Bar
Loading chart for PHG
  • Previous Close 27.12
  • Open 27.39
  • Bid 24.00 x 50000
  • Ask 27.40 x 70000
  • Day's Range 26.86 - 27.39
  • 52 Week Range 23.62 - 33.44
  • Volume 1,273,375
  • Avg. Volume 965,960
  • Market Cap (intraday) 26.312B
  • Beta (5Y Monthly) 0.92
  • PE Ratio (TTM) 20.09
  • EPS (TTM) 1.34
  • Earnings Date Nov 3, 2026
  • Forward Dividend & Yield 1.01 (3.76%)
  • 1y Target Est 32.02
  • Morningstar Rating Rating available with Stock Picks access

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

www.philips.com

63,670

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is AEX-Index (^AEX) .

YTD Return

PHG
3.28%
AEX-Index (^AEX)
19.25%

1-Year Return

PHG
2.56%
AEX-Index (^AEX)
15.57%

3-Year Return

PHG
56.33%
AEX-Index (^AEX)
58.87%

5-Year Return

PHG
35.89%
AEX-Index (^AEX)
39.90%

Earnings Trends

View More

Earnings Per Share (Normalized)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 4.36B
Earnings 384M
Profit Margin 8.81%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
1B
2B
3B
4B
5B
4.0%
5.0%
6.0%
7.0%
8.0%

Analyst Insights

View More

Analyst Price Targets

26.20
32.02 Average
26.92 Current
41.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/3/2026
Analyst UBS
Rating Action Downgrade
Rating Neutral
Price Action --
Price Target --

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.31%

  • Return on Assets (ttm)

    4.07%

  • Return on Equity (ttm)

    10.15%

  • Revenue (ttm)

    17.66B

  • Net Income Avi to Common (ttm)

    1.11B

  • Diluted EPS (ttm)

    1.34

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.79B

  • Total Debt/Equity (mrq)

    65.05%

  • Levered Free Cash Flow (ttm)

    1.53B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: